Fiche publication
Date publication
mai 2026
Journal
Journal of pharmaceutical and biomedical analysis
Auteurs
Membres identifiés du Cancéropôle Est :
Dr PFEFFER Sébastien
Tous les auteurs :
Adouairi K, Farre C, Chaix C, Pfeffer S, Faure K
Lien Pubmed
Résumé
Chemical modifications on oligonucleotides, notably N-6-methyladenosine (mA) are known for their impact on diverse classes of RNA including micro (mi)RNAs. However, the characterization of these modifications on intact sequences remains challenging. An ion-pair free hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry (HILIC-HRMS/MS) workflow was developed for the intact analysis of miRNA analogues within synthesis batches, with length up to 22 nucleotides, including sequences differing by an increase in methylation levels and positional isomers containing the same number of methyl groups. The method combines amide-based HILIC separation to top-down collision-induced dissociation (CID) MS/MS and delivers three levels of characterization in a 20-min single run. It allows (i) the separation and identification of impurities (shortmers) from full length product (FLP), (ii) the chromatographic resolution of global methylation forms (0, 1 and 2 methyl groups) up to 22-mer sequence length and (iii) positional isomers discrimination based on the presence and/or absence of specific fragments. The application of HILIC-MS/MS workflow on complex samples, such as positional isomers with identical mA counts and non-equimolar mixtures of various methylation levels, demonstrated robust identification of each isomer, including in mixed samples and despite differences in isomer concentration.
Mots clés
HILIC, HILIC-HRMS, Modified oligonucleotides, Positional miRNA isomers, Tandem mass spectrometry (MS/MS)
Référence
J Pharm Biomed Anal. 2026 05 4;278:117546